Protagonist Therapeutics, Inc Quarterly Current Ratio in % from Q1 2017 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Protagonist Therapeutics, Inc quarterly Current Ratio history and growth rate from Q1 2017 to Q2 2024.
  • Protagonist Therapeutics, Inc Current Ratio for the quarter ending June 30, 2024 was 1.44K %, a 57.7% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 1.44K +526 +57.7% Jun 30, 2024
Q1 2024 1.41K +600 +74.3% Mar 31, 2024
Q4 2023 1.25K +479 +62.3% Dec 31, 2023
Q3 2023 1.03K +262 +34.1% Sep 30, 2023
Q2 2023 912 +124 +15.7% Jun 30, 2023
Q1 2023 807 -7.3 -0.9% Mar 31, 2023
Q4 2022 769 -55.8 -6.76% Dec 31, 2022
Q3 2022 769 -60.3 -7.27% Sep 30, 2022
Q2 2022 788 +35.2 +4.67% Jun 30, 2022
Q1 2022 815 +127 +18.4% Mar 31, 2022
Q4 2021 825 +252 +43.9% Dec 31, 2021
Q3 2021 829 +353 +74.3% Sep 30, 2021
Q2 2021 753 +294 +64.1% Jun 30, 2021
Q1 2021 688 +281 +69.1% Mar 31, 2021
Q4 2020 573 +130 +29.4% Dec 31, 2020
Q3 2020 476 +3.4 +0.72% Sep 30, 2020
Q2 2020 459 -45.7 -9.06% Jun 30, 2020
Q1 2020 407 -118 -22.4% Mar 31, 2020
Q4 2019 443 -54.4 -10.9% Dec 31, 2019
Q3 2019 472 +27.1 +6.09% Sep 30, 2019
Q2 2019 505 +170 +51% Jun 30, 2019
Q1 2019 524 +191 +57.4% Mar 31, 2019
Q4 2018 498 +153 +44.6% Dec 31, 2018
Q3 2018 445 +26.2 +6.25% Sep 30, 2018
Q2 2018 334 -780 -70% Jun 30, 2018
Q1 2018 333 -830 -71.4% Mar 31, 2018
Q4 2017 344 Dec 31, 2017
Q3 2017 419 Sep 30, 2017
Q2 2017 1.11K Jun 30, 2017
Q1 2017 1.16K Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.